The Unseen Epidemic of Corneal Neuropathic Pain
Netra Restoration Therapy (NRT) is designed based on a holistic neuro-restorative framework by targeting specific molecular and vascular pathways.

Corneal dystrophy refers to a group of genetic conditions where cloudy material builds up within the cornea. This buildup often happens in both eyes and progresses slowly over time. Patients typically notice blurred vision or a painful sensation as the cornea loses its transparency. Because these changes occur in different layers of the eye, finding the right Corneal Dystrophy Treatment is essential to maintain your visual clarity and daily comfort.
Netra Eye Institute provides a specialized corneal dystrophy treatment that avoids surgical intervention. Our team focuses on holistic eye care and wellness by using time-tested traditions like Ayurveda and Traditional Chinese Medicine. As a dedicated eye care institute, we offer eye care therapy rooted in herbal medicine and acupuncture to support your ocular health. We work to nourish your eyes naturally and manage the symptoms associated with corneal clouding. Our practitioners guide you through a corneal dystrophy treatment plan designed to balance your body and protect your vision without the need for invasive procedures.
Netra Restoration Therapy (NRT) is designed based on a holistic neuro-restorative framework by targeting specific molecular and vascular pathways.

Understanding Corneal Pain
If you've been experiencing persistent eye pain, burning, or discomfort—especially after LASIK surgery—you may be suffering from a condition called Corneal Neuropathy. At Netra Eye Institute, we understand how frustrating it can be when your eyes hurt but doctors tell you everything "looks normal." Let us answer the most common questions about this condition in simple, easy-to-understand language.
What Are Corneal Nerves?
Imagine the surface of your eye as having thousands of tiny sensors—like the sensitive tips of your fingers. These sensors (nerves) are incredibly dense. In fact, your cornea has 300 to 600 times more nerve endings than your skin. That's why even a tiny speck of dust feels so noticeable!These nerves do two important jobs:1. They protect you by making you blink or tear up when something irritates your eye2. They keep your eye healthy by releasing special "food" (call as neurotrophic factors) that keeps the surface cells of your eye alive and well.
Lowering IOP is important, but not always enough
Studies show that 30–40% of glaucoma patients continue to lose vision despite maintaining normal eye pressure. This highlights the need for a more comprehensive glaucoma treatment approach that goes beyond just IOP management.
Individualized care is essential
These patients may require more than just IOP-lowering treatments. For instance, neuroprotective strategies targeting the optic nerve or treatments to improve ocular blood flow to the retina and optic nerve may be considered to reduce progression.
What causes continued vision loss in glaucoma?
Multiple research studies have shown factors such as lack of neuroprotection, reduced ocular blood flow, neurotrophin deprivation, increased oxidative stress, ocular inflammation and excitotoxicity can all  contribute to vision loss progression in Glaucoma.
You may have Corneal Neuropathy damage to the tiny nerves in your cornea. Think of it like this: the wires (nerves) that should be sending normal signals to your brain are damaged, so they send pain signals instead. Just like a bad wire in your house can cause problems even though the light bulb looks fine, your eye surface can look healthy while the nerves underneath are in faulty.

Normal Tension Glaucoma (NTG) is a type of glaucoma in which optic nerve damage and vision loss occur despite eye pressure remaining within the normal range. In NTG, pressure alone does not explain the disease; instead, the optic nerve is thought to be more vulnerable due to factors such as reduced blood flow, impaired circulation regulation, increased nerve sensitivity, oxidative stress, and reduced neuroprotection. Because of this heightened susceptibility, even normal eye pressure can contribute to progressive damage over time.
The mean percentage of NTG in all patients diagnosed with a glaucomatous visual field defect is between 30% and 40%.
NTG is especially common in Asian populations, where it can account for a majority of primary open-angle glaucoma (POAG) cases—often exceeding 70–90%. This highlights that glaucoma is not solely a pressure-related condition, but a complex disease influenced by overall optic nerve health and systemic factors.
The prevalence of NTG has been reported to be 92.3% in Japan, 84.6% in Singapore, 83.58% in Northern China, 82% in South India, 79.3% in Southern China, 77% in South Korea, 57.1% in South Africa, 46.9% in Iran, 38.9% in Netherlands, 31.7% in the United States, 31.0% in Iceland, and 30.0% in Italy.
Normal Tension Glaucoma (NTG) patients often requires more than just eye-pressure–lowering drops because eye pressure is not their main cause of glaucomatous vision loss. In NTG, vision loss can occur even when eye pressure is normal, due to reduced blood flow to the optic nerve, poor regulation of blood vessels, increased inflammation, oxidative stress, and reduced support for the nerve cells that carry visual signals to the brain. While eye drops may help lower pressure slightly and remain part of treatment, they do not improve optic nerve blood flow or protect nerve cells from ongoing injury. For this reason, NTG care often needs a broader approach that supports optic nerve health, stabilizes blood flow, and addresses the underlying factors contributing to nerve damage—beyond eye pressure alone.
Our signature Netra Restoration Therapy is a unique treatment method available exclusively at Netra Eye Institute, which has shown to halt AMD progression, improve visual acuity, reduce foggy/hazy vision, improve contrast sensitivity and  reduce glare.
The Mechanism of Action (MOA) of Netra Restoration Therapy works by enhancing ocular blood flow through the regulation of vascular function, reducing oxidative stress and ocular inflammation, increasing neurotrophin levels and neuroprotection, and reducing ferroptosis.
The potential for visual improvement depends on the severity of retinal damage present at the time of treatment for Wet AMD. Taking these factors into account, our therapeutic approach has been shown to result in:

Stops vision loss progression by reducing the ocular inflammation, regulating ocular blood flow and nourshing the retinal cells.

Improvement in visual field by restoring
dormant and unhealthy retinal cells.

An improvement of at least one line on the distance and near vision eye chart.

Improved contrast vision, making it easier to distinguish shapes, edges, and details.

Improvement in color, brightness perception and clarity making it easier to see in low-light or nighttime conditions, thereby supporting safer mobility and daily activities.

Reduced glare, less light sensitivity, and improved comfort in bright environments, such as sunlight, headlights, or digital screens.

Patients experience considerable reduction
in eye pain and eye strains.

Patients often report feeling “healthier overall,” not just in their eyes.
Netra Restoration Therapy is grounded in contemporary biomedical research demonstrating that many eye diseases are driven by reduced ocular blood flow, ongoing neurodegeneration, and cellular stress. Scientific studies show that improving vascular regulation enhances oxygen and nutrient delivery to the retina and optic nerve, while supporting neurotrophin activity and neuroprotection helps preserve vulnerable nerve cells. At the same time, controlling oxidative stress, ferroptosis, and chronic inflammation is critical to slowing tissue damage and disease progression. Netra Restoration integrates these evidence-based principles into a comprehensive approach designed to support long-term eye health and visual function.